# Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.

> **NCT01476046** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 56 (actual)

## Conditions studied

- Respiratory Disorders

## Interventions

- **DRUG:** GSK1995057 single dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01476046
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-08
- **Primary completion:** 2012-06-17
- **Final completion:** 2012-06-17
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01476046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01476046, "Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01476046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*